![PDF) Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali PDF) Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali](https://i1.rgstatic.net/publication/275048379_Molecular_characteristics_of_Hepatitis_B_and_chronic_liver_disease_in_a_cohort_of_HB_carriers_from_Bamako_Mali/links/553a30500cf29b5ee4b457bf/largepreview.png)
PDF) Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali
![PDF) Meta‐analysis: Enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases PDF) Meta‐analysis: Enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases](https://i1.rgstatic.net/publication/367219923_Meta-analysis_Enhanced_liver_fibrosis_test_to_identify_hepatic_fibrosis_in_chronic_liver_diseases/links/63c79978d9fb5967c2e55c35/largepreview.png)
PDF) Meta‐analysis: Enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases
Dosage immunoturbidimétrique de l'alpha 2 macroglobuline (réactifs DakoCytomation) sur les automates Roche Diagnostics (Modu
![PDF) The role of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in the assessment of fibrosis in children with chronic hepatitis C PDF) The role of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in the assessment of fibrosis in children with chronic hepatitis C](https://i1.rgstatic.net/publication/361687556_The_role_of_serum_Wisteria_floribunda_agglutinin-positive_Mac-2_binding_protein_in_the_assessment_of_fibrosis_in_children_with_chronic_hepatitis_C/links/62bfae78894d625717bfa889/largepreview.png)
PDF) The role of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in the assessment of fibrosis in children with chronic hepatitis C
![WO2015197934A1 - Synergistic combination of biomarkers for detecting and assessing hepatic fibrosis - Google Patents WO2015197934A1 - Synergistic combination of biomarkers for detecting and assessing hepatic fibrosis - Google Patents](https://patentimages.storage.googleapis.com/01/c4/0b/a5993600b94b13/imgf000012_0001.png)
WO2015197934A1 - Synergistic combination of biomarkers for detecting and assessing hepatic fibrosis - Google Patents
![Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus | SpringerLink Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00261-018-1572-6/MediaObjects/261_2018_1572_Fig2_HTML.jpg)
Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus | SpringerLink
![John Libbey Eurotext - Médecine de la Reproduction - Impact on MPA of improvement and reimbursement of hepatitis C treatment John Libbey Eurotext - Médecine de la Reproduction - Impact on MPA of improvement and reimbursement of hepatitis C treatment](https://www.jle.com/e-docs/00/04/C5/BA/jlemte0691gr1.jpg)